Wallqvist A - Search Results

1

Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action.

Huang R, Wallqvist A, Covell DG. Huang R, et al. Among authors: wallqvist a. J Med Chem. 2006 Mar 23;49(6):1964-79. doi: 10.1021/jm051029m. J Med Chem. 2006. PMID: 16539384

2

Mining the NCI screening database: explorations of agents involved in cell cycle regulation.

Wallqvist A, Monks A, Rabow AA, Thanki N, Shoemaker RH, Covell DG. Wallqvist A, et al. Prog Cell Cycle Res. 2003;5:173-9. Prog Cell Cycle Res. 2003. PMID: 14593711 Review.

3

Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data.

Wallqvist A, Rabow AA, Shoemaker RH, Sausville EA, Covell DG. Wallqvist A, et al. Bioinformatics. 2003 Nov 22;19(17):2212-24. doi: 10.1093/bioinformatics/btg302. Bioinformatics. 2003. PMID: 14630650

4

Anticancer metal compounds in NCI's tumor-screening database: putative mode of action.

Huang R, Wallqvist A, Covell DG. Huang R, et al. Among authors: wallqvist a. Biochem Pharmacol. 2005 Apr 1;69(7):1009-39. doi: 10.1016/j.bcp.2005.01.001. Biochem Pharmacol. 2005. PMID: 15763539 Review.

5

Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases.

Covell DG, Wallqvist A, Huang R, Thanki N, Rabow AA, Lu XJ. Covell DG, et al. Among authors: wallqvist a. Proteins. 2005 May 15;59(3):403-33. doi: 10.1002/prot.20392. Proteins. 2005. PMID: 15778971 Review.

6

Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen.

Huang R, Wallqvist A, Covell DG. Huang R, et al. Among authors: wallqvist a. Genomics. 2006 Mar;87(3):315-28. doi: 10.1016/j.ygeno.2005.11.011. Epub 2006 Jan 4. Genomics. 2006. PMID: 16386875 Free article.

7

Evaluating chemical structure similarity as an indicator of cellular growth inhibition.

Wallqvist A, Huang R, Thanki N, Covell DG. Wallqvist A, et al. J Chem Inf Model. 2006 Jan-Feb;46(1):430-7. doi: 10.1021/ci0501544. J Chem Inf Model. 2006. PMID: 16426077

8

Chemoinformatic analysis of NCI preclinical tumor data: evaluating compound efficacy from mouse xenograft data, NCI-60 screening data, and compound descriptors.

Wallqvist A, Huang R, Covell DG. Wallqvist A, et al. J Chem Inf Model. 2007 Jul-Aug;47(4):1414-27. doi: 10.1021/ci700132u. Epub 2007 Jun 8. J Chem Inf Model. 2007. PMID: 17555311

9

Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data.

Covell DG, Huang R, Wallqvist A. Covell DG, et al. Among authors: wallqvist a. Mol Cancer Ther. 2007 Aug;6(8):2261-70. doi: 10.1158/1535-7163.MCT-06-0787. Mol Cancer Ther. 2007. PMID: 17699723

10

Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors.

Rice WG, Turpin JA, Schaeffer CA, Graham L, Clanton D, Buckheit RW Jr, Zaharevitz D, Summers MF, Wallqvist A, Covell DG. Rice WG, et al. Among authors: wallqvist a. J Med Chem. 1996 Sep 13;39(19):3606-16. doi: 10.1021/jm960375o. J Med Chem. 1996. PMID: 8809151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters